DEF 14A

Company

Enveric Biosciences, Inc.

Filed

September 27, 2019

Period of Report

October 29, 2019

Accession Number

0001140361-19-017341

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →